UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | Â (1) | 04/22/2025 | Common Stock | 12,303 | $ 9.6 | D | Â |
Employee Stock Option (right to buy) | Â (2) | 03/07/2026 | Common Stock | 2,355 | $ 12.21 | D | Â |
Employee Stock Option (right to buy) | Â (3) | 03/03/2027 | Common Stock | 19,800 | $ 22.3 | D | Â |
Restricted Stock Units | Â (5) | Â (5) | Common Stock | 5,300 | $ (4) | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Cappucci Gabriel R. C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE, NY 10577 |
 |  |  Senior VP, Controller and CAO |  |
/s/ Adam C. Vandervoort, attorney-in-fact | 01/04/2019 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The option vested as to 25% of the shares on April 22, 2016. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. |
(2) | The option vested as to 25% of the shares on March 7, 2017. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. |
(3) | The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. |
(4) | Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. |
(5) | The restricted stock unit vests in three equal annual installments beginning March 1, 2019. |